Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025

An Update on Pulmonary Drug Delivery of Dry Powders

Inhalation of air is a vital process for all human life. Inhalation
for drug delivery has been established as an effective delivery
method of active pharmaceutical ingredients to a human
body, mostly in the field of anesthesia and respiratory
diseases. In this article, the status and new trends in the
field of drug delivery to the lungs will be reviewed by Rachel
van Rijn and Harry Peters of DFE Pharma, with focus on the
delivery of active pharmaceutical ingredients (APIs) in the
form of dry powders.
https://international-pharma.com/wp-content/uploads/2018/04/An-update-on-pulmonary-drug-delivery.pdf

Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025